chr16-4799729-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024589.3(ROGDI):c.389G>A(p.Arg130Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000397 in 1,613,560 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R130P) has been classified as Uncertain significance.
Frequency
Consequence
NM_024589.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ROGDI | NM_024589.3 | c.389G>A | p.Arg130Gln | missense_variant | Exon 6 of 11 | ENST00000322048.12 | NP_078865.1 | |
ROGDI | XM_006720947.5 | c.389G>A | p.Arg130Gln | missense_variant | Exon 6 of 11 | XP_006721010.1 | ||
ROGDI | XM_047434636.1 | c.119G>A | p.Arg40Gln | missense_variant | Exon 4 of 9 | XP_047290592.1 | ||
ROGDI | NR_046480.2 | n.396G>A | non_coding_transcript_exon_variant | Exon 5 of 10 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152070Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000598 AC: 15AN: 250676Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135564
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461490Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 727064
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152070Hom.: 0 Cov.: 33 AF XY: 0.0000808 AC XY: 6AN XY: 74276
ClinVar
Submissions by phenotype
Amelocerebrohypohidrotic syndrome Uncertain:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 130 of the ROGDI protein (p.Arg130Gln). This variant is present in population databases (rs374603311, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ROGDI-related conditions. ClinVar contains an entry for this variant (Variation ID: 530798). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.389G>A (p.R130Q) alteration is located in exon 6 (coding exon 6) of the ROGDI gene. This alteration results from a G to A substitution at nucleotide position 389, causing the arginine (R) at amino acid position 130 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at